Overview
Salaries
Products
People
Growth
Offices
Financials

Investor profile

Venture capital
Investments
172
103 of them startups
Hiring now
44
3,511 open roles
Deals in 12 months
1
Rounds in 12 months
14
$994.2M raised
Exits
9
2 closed
Focusshare of its companies
Cell & Gene Therapy 3%AI Research Labs 3%Drug Discovery 3%Decision Intelligence 3%Foundation Models 3%LLM & Generative AI 2%Genomics & Genetic Testing 2%Supply Chain 2%
Where its companies are
United States 23%United Kingdom 4%Estonia 3%Lithuania 1%Latvia 1%Bangladesh 1%Canada 1%Iceland 1%
Stage of its companies
Venture, series not stated 68%Series C and later 11%Series A 8%Series B 8%Pre-seed & seed 6%
Similar investorstheir companies share markets and countries
Sources: its portfolio page, read Oct 4; 1 rounds in the press that name it

Overview

An early-stage investment firm making long-term bets on contrarians and leveraging the knowledge and network across sectors. We back mission-driven founders working on positively disruptive deep technologies.

Financials

Total raised
$350k
Latest round
Grant
Funding rounds
1
Funding rounds
Round Announced Amount
Grant 2026 $350k Details